MicroRNA-147 induces a mesenchymal-to-epithelial transition (MET) and reverses EGFR inhibitor resistance.
The epithelial-mesenchymal transition (EMT) is a key developmental program that is often activated during cancer progression and may promote resistance to therapy. An analysis of patients (n = 71) profiled with both gene expression and a global microRNA assessment (∼ 415 miRs) identified miR-147 as...
Main Authors: | Chang Gong Lee, Susan McCarthy, Mike Gruidl, Cindy Timme, Timothy J Yeatman |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3893127?pdf=render |
Similar Items
-
A case of EGFR mutant lung adenocarcinoma that acquired resistance to EGFR-tyrosine kinase inhibitors with MET amplification and epithelial-to-mesenchymal transition
by: Miyoshi S, et al.
Published: (2015-04-01) -
MicroRNA-7 inhibits tumor metastasis and reverses epithelial-mesenchymal transition through AKT/ERK1/2 inactivation by targeting EGFR in epithelial ovarian cancer.
by: Xingchen Zhou, et al.
Published: (2014-01-01) -
Osteoglycin (OGN) reverses epithelial to mesenchymal transition and invasiveness in colorectal cancer via EGFR/Akt pathway
by: Xiang Hu, et al.
Published: (2018-03-01) -
Sox2, an EGFR induced transcriptional factor, modulates cell growth and mesenchymal-epithelial trans-differentiation (MET) of lung cancer.
by: Chih-Chan Lee, et al.
Published: (2010) -
Grape seed proanthocyanidins inhibit the invasiveness of human HNSCC cells by targeting EGFR and reversing the epithelial-to-mesenchymal transition.
by: Qian Sun, et al.
Published: (2012-01-01)